2025 second_quarter Filing
RRFiled
June 30, 2025
Lobbying Activities
Health IssuesView all
advocacy and education around the company's value proposition to advance medicines to break the cycle of alcohol and drug dependence.
Lobbyists (2)
ERIK DELL
NewMARK F LINDSAY
U.S House Staff
New